Adamantinomatous craniopharyngioma: evolution in the management.
Massimi L, Palombi D, Musarra A, Bianchi F, Frassanito P, Tamburrini G, Di Rocco C.
Childs Nerv Syst. 2023 Oct;39(10):2613-2632. doi: 10.1007/s00381-023-06143-4. Epub 2023 Sep 20.
Adamantinomatous craniopharyngioma: advances in proteomic research.
Desiderio C, Rossetti DV, Castagnola M, Massimi L, Tamburrini G.
Childs Nerv Syst. 2021 Mar;37(3):789-797. doi: 10.1007/s00381-020-04750-z. Epub 2020 Jul 2.
Craniopharyngioma.
Müller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S.
Nat Rev Dis Primers. 2019 Nov 7;5(1):75. doi: 10.1038/s41572-019-0125-9.
Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis.
Gonzalez-Meljem JM, Martinez-Barbera JP.
Cell Mol Life Sci. 2021 May;78(10):4521-4544. doi: 10.1007/s00018-021-03798-7. Epub 2021 Mar 26.
Single-cell RNA sequencing highlights intratumor heterogeneity and intercellular network featured in adamantinomatous craniopharyngioma.
Jiang Y, Yang J, Liang R, Zan X, Fan R, Shan B, Liu H, Li L, Wang Y, Wu M, Qi X, Chen H, Ren Q, Liu Z, Wang Y, Zhang J, Zhou P, Li Q, Tian M, Yang J, Wang C, Li X, Jiang S, Zhou L, Zhang G, Chen Y, Xu J.
Sci Adv. 2023 Apr 14;9(15):eadc8933. doi: 10.1126/sciadv.adc8933. Epub 2023 Apr 12.
Adamantinomatous craniopharyngioma in the molecular age and the potential of targeted therapies: a review.
Whelan R, Hengartner A, Folzenlogen Z, Prince E, Hankinson TC.
Childs Nerv Syst. 2020 Aug;36(8):1635-1642. doi: 10.1007/s00381-020-04677-5. Epub 2020 May 22.
Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models.
Martinez-Barbera JP, Buslei R.
J Pediatr Endocrinol Metab. 2015 Jan;28(1-2):7-17. doi: 10.1515/jpem-2014-0442.
Adamantinomatous craniopharyngioma: moving toward targeted therapies.
Hengartner AC, Prince E, Vijmasi T, Hankinson TC.
Neurosurg Focus. 2020 Jan 1;48(1):E7. doi: 10.3171/2019.10.FOCUS19705.
Adamantinomatous craniopharyngioma cyst fluid can trigger inflammatory activation of microglia to damage the hypothalamic neurons by inducing the production of beta-amyloid.
Ainiwan Y, Chen Y, Mao C, Peng J, Chen S, Wei S, Qi S, Pan J.
J Neuroinflammation. 2022 May 7;19(1):108. doi: 10.1186/s12974-022-02470-6.
Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice.
Apps JR, Martinez-Barbera JP.
Neurosurg Focus. 2016 Dec;41(6):E4. doi: 10.3171/2016.8.FOCUS16307.
